Actively Recruiting

All Genders
ID03309384

Intraoperative Monitoring (Parathormone Values and Continuous Neuromonitoring) to Predict Postoperative Complications After Total Thyroidectomy

Led by Central Hospital, Nancy, France · Updated on 2025-02-12

1000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate how intraoperative continuous and intermittent neuromonitoring, along with intraoperative parathormone (PTH) levels, can help predict nerve problems and low calcium levels after thyroid removal surgery. The study focuses on patients undergoing total thyroidectomy, assessing complications related to the parathyroid glands and laryngeal nerves. It is an observational study conducted by Central Hospital, Nancy, France, to better understand postoperative risks. During surgery, continuous neuromonitoring and measurements of parathormone levels will be collected from patients having total thyroidectomy. These intraoperative data points are used to predict postoperative complications such as nerve injury and hypocalcemia. The study does not involve any experimental treatment but follows patients prospectively to observe outcomes. Participants will be monitored for nerve issues and calcium-related problems within the first week after surgery and again one year later. Validated classifications will be used to evaluate other complications at one year. Researchers will collect data on postoperative nerve function, calcium levels, and parathyroid function to assess the predictive value of intraoperative monitoring and PTH measurements. The total participation duration includes follow-up visits up to one year after surgery.

CONDITIONS

Brief Title

Intraoperative Monitoring to Predict Postoperative Complications After Thyroidectomy

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients scheduled for total thyroidectomy at University Hospital in Nancy
Not Eligible

You will not qualify if you...

  • Refusal to participate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - Up to 4 weeks

Participants are screened for eligibility to participate in the trial.

Surgery and Immediate Post-operative Care

Duration - Day of surgery and up to 1 week after surgery

Participants undergo total thyroidectomy with intraoperative monitoring of parathormone values and continuous neuromonitoring.

1 visit during surgery and follow-up assessments within 1 week after thyroidectomy

Long-term Monitoring

Duration - Up to 1 year after surgery

Participants are monitored for postoperative complications including hypocalcemia, hypoparathyroidism, and laryngeal nerve palsy at 1 year after thyroidectomy.

1 follow-up visit at 1 year post-thyroidectomy

Trial Site Locations

Total: 1 location

1

CHU Nancy

Vandœuvre-lès-Nancy, France, 54511

Actively Recruiting

Loading map...

Research Team

B

Brunaud

J

Jacquel

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Outcomes of Patients With Thyroid Carcinoma Treated With Red...

Thyroid Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here